Clinical Trial Summary

National Health Services (NHS) Royal Free Hospital ,London 2010

  • 16 week clinical trial  in 900 bedded facility - 8,500 air and surface samples - 21 locations around hospital
  • 97% reduction in MRSA and Prevent spread of Infection
  • 75% reduction in surface bacterial counts

Uzsoki Hospital, Hungary - Pulmonology Department (Oct 2014 - Feb 2015)

  • 4 months Clinical study in 870 bed hospital in Budapest, One of the 6 regional centres with an affiliate of 400 beds.
  • 82% drop in CFU rates (T0(Oct) / T4 average (Feb)
  • Average reduction of bacterial count by 52% & Fungal Count by 93%
  • The air quality now meets the Swiss Class III standard (500 CFU/m3 for general wards).

Rigshospitalet, Denmark (March 2014)

A 9 month study was carried out at Rigshospitalet, a highly specialized hospital with 1100 beds. Tests were performed by the Laboratory of Infection Hygiene and the Department of Clinical Microbiology. Infection rate was increased to 35 % without Novaerus Air Sterilizer & Infection Rate fallen by 23 % in with Novaerus.

Page Rehabilitation & Health Center USA 2012- 2013

  • 12 months clinical trial in 44 bedded special Care Unit
  • Total Hospital Associated Infection Reduction to Average 56 % in 12 months.
  • Infection rate reduced to 75%

Regents Park Of Boca Ration City, Florida USA Jul 2013 – Feb 2014

  • 24 months Clinical study in 180 bedded facility .
  • 52.3% drop in Hospital Associated Infection in 3 months

Hialeah Nursing and Rehabilitation Centre (HNRC) 2012-2014

  • 28 months Trial in 276 bedded facility providing long & Short term rehabilitation.
  • Infection rate was reduced to 33% for Hospital Associated Infection and 100% for C.Diff
  • Repeat infection rate declined by 37.5%

Institute of Schwarzkopf 2014

  • 900 bedded facility in Great Britain London in a cross over study
  • Contamination rate was reduced to 23% for Floors & 68% on tables .
  • On an average Total 49% reduction in Infection rate and prevents spread of Infection .

Manchester Manor, Florida USA Jun 2013- Feb 2014

  • 11 months clinical trial in 120 bedded Facility for C. Difficile & Respiratory Infections
  • C. Difficile Infection reduced to 50%
  • Respiratory Infections reduced to 42.86%

Torres Vedras & Alverica Facility of Fresenius Dialysis Unit , Portugal 2014

  • 6 weeks of clinical trial with 30 stations of Dialysis
  • 87 % reduction in Airborne Bacterial count
  • 93 % Reduction in VOC’S
  • 67% Reduction in Moulds

West Gables Health Care Center, Miami ,Florida USA 2014

  • 2 months Trial in 120 bedded facility providing post acute medical cato patient care.
  • Re admission rate of Patient with Pneumonia Receded to 62.5%

Bucharist Emergency University Hospital ,Jun 2015 – Sep 2015

  • 90 days/3 months Clinical Trial , 336 air samples were taken from 3 different points in 7 locations.
  • 87 % Reduction in Fungal count & 89 % in Bacterial Count.
  • 100% Reduction for Staphylococcus CFU.

Międzyrzecz Hospital Romania , Jul2015- Aug 2015

  • CFU reduced to 72 from 183 i.e 61 %